Gene · 51548
Papers4,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lysophosphatidylethanolamine 18:1 drives clear cell renal cell carcinoma by stabilizing SIRT6 to reprogram lipid metabolism. | Signal Transduct Target Ther | 2025 | 41354870 | PubTator, text mining | PubMed |
| Aging hearts, fibrotic fears: The sirtuin connection. | Biomed Pharmacother | 2025 | 41349250 | PubTator, text mining | PubMed |
| USP54 suppresses bladder cancer proliferation, stemness, and cisplatin resistance via deubiquitination-mediated stabilization of SIRT6. | J Chemother | 2025 | 41299845 | PubTator, text mining | PubMed |
| Ferroptosis in Anaplastic Thyroid Cancer: Molecular Mechanisms, Preclinical Evidence, and Therapeutic Prospects. | Cells | 2025 | 41294853 | PubTator, text mining | PubMed |
| The association of the SIRT6 rs117385980 variant with frailty and longevity: an exploratory study. | Sci Rep | 2025 | 41249831 | PubTator, text mining | PubMed |
| Upregulation of SIRT6 enhances autophagy-dependent ferroptosis of colorectal cancer cells through inactivating the mTOR/STAT3 signaling pathway. | Neoplasma | 2025 | 41235530 | PubTator, text mining | PubMed |
| Histone probes for reader and eraser investigations. | Chem Sci | 2025 | 41164300 | PubTator, text mining | PubMed |
| SIRT1/3/6 Landscape of Human Longevity: A Sex- and Health-Stratified Pilot Study. | Biology (Basel) | 2025 | 41154755 | PubTator, text mining | PubMed |
| Sirtuin Family in Acute Kidney Injury: Insights into Cellular Mechanisms and Potential Targets for Treatment. | Biomolecules | 2025 | 41154674 | PubTator, text mining | PubMed |
| The Influence of Sirtuin 6 on Chondrocyte Senescence in Osteoarthritis Under Aging: Focusing on Mitochondrial Dysfunction and Oxidative Stress. | Antioxidants (Basel) | 2025 | 41154537 | PubTator, text mining | PubMed |
| Global Profiling of Lysine Lactylation in Prostate Cancer Cells. | Cancer Genomics Proteomics | 2025 | 41151862 | PubTator, text mining | PubMed |
| Pharmacological activation of SIRT6 suppresses progression of head and neck and esophageal squamous cell carcinoma by modulation of cellular metabolism and protein translation. | Cell Death Dis | 2025 | 41102169 | PubTator, text mining | PubMed |
| A phase 2, multicenter, double-blind, randomized, placebo-controlled study of the safety and efficacy of forvisirvat (SP-624) in the treatment of adults with major depressive disorder. | Curr Med Res Opin | 2025 | 41099447 | PubTator, text mining | PubMed |
| The crosstalk between MicroRNAs and sirtuins: a bit unexpected therapeutic target for cardiovascular diseases. | Eur J Med Res | 2025 | 41088315 | PubTator, text mining | PubMed |
| SIRT6 in health and diseases: From molecular mechanisms to therapeutic prospects. | Pharmacol Res | 2025 | 41075996 | PubTator, text mining | PubMed |
| Sirtuin 6 is a histone delactylase. | J Biol Chem | 2025 | 41062064 | PubTator, text mining | PubMed |
| Ultraviolet-B Irradiation Induces miR-663a and miR-4706 Accelerated Photoaging by Targeting Sirtuin 6 in Human Dermal Fibroblasts. | Photodermatol Photoimmunol Photomed | 2025 | 41039700 | PubTator, text mining | PubMed |
| Association of SIRT1 rs12415800 and SIRT6 rs350844 polymorphisms with preeclampsia: A case-control study. | Pregnancy Hypertens | 2025 | 41027397 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers for hepatocellular carcinoma based on the m6A RNA modification. | Int J Immunopathol Pharmacol | 2025 | 41013996 | PubTator, text mining | PubMed |
| Sirtuin-mediated modulation of cardiac fibrosis: Emerging molecular insights and therapeutic perspectives. | Pharmacol Res | 2025 | 41005588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51548/papers?page=9